Alpha 2.0
Login Register
» Articles » PMID: 779424

Immunotherapy of Gliomas: a Review

Overview
Journal Adv Neurol
Specialty Neurology
Date 1976 Jan 1
PMID 779424
Citations 10
Authors
A K Ommaya
Affiliations
Soon will be listed here.
Citing Articles

Microbial immunomodulators: mannoprotein constituents ofCandida albicans with immunomodulatory activity in lymphocyte cultures of normal, glioma-bearing and HIV-infected subjects.

Cassone A, Quinti I, Ausiello C, Palma C, Gomez M, Maleci A Cytotechnology. 2012; 5(Suppl 1):7-10.

PMID: 22358941 DOI: 10.1007/BF00736795.

The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Heimberger A, Sampson J Expert Opin Biol Ther. 2009; 9(8):1087-98.

PMID: 19591631 PMC: 2793529. DOI: 10.1517/14712590903124346.

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Sampson J, Archer G, Mitchell D, Heimberger A, Bigner D Semin Immunol. 2008; 20(5):267-75.

PMID: 18539480 PMC: 2633865. DOI: 10.1016/j.smim.2008.04.001.

A study of reactions to Corynebacterium parvum (C. parvum) in the brain and dermis of the rat.

Cravioto H, Hochwald G, Ransohoff J Acta Neuropathol. 1982; 56(1):35-44.

PMID: 7064658 DOI: 10.1007/BF00691180.

Immunobiologic aspects of the brain and human gliomas. A review.

Wikstrand C, Bigner D Am J Pathol. 1980; 98(2):517-68.

PMID: 6986786 PMC: 1903417.